NCT07823283

Brief Summary

This study is being done to see whether signals from a device that monitors blood flow through the free flap can be recorded and converted from an audible signal, like a heartbeat, into a visual signal. Researchers plan to use this information to ultimately help surgeons and care teams monitor free flaps to try to prevent flap failure.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
24mo left

Started Sep 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Sep 2026Sep 2028

First Submitted

Initial submission to the registry

September 11, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 16, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

September 17, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2028

Last Updated

September 21, 2026

Status Verified

September 1, 2026

Enrollment Period

2 years

First QC Date

September 11, 2026

Last Update Submit

September 17, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility - record audible doppler signal tracings

    Ability to record a minimum of 2 audible doppler signal tracings from the implantable doppler per 24 hours for a minimum of one 24 hour period for 80% of subjects. Analysis of the primary endpoint will be done in a binary (yes/no) fashion to describe the feasibility of the proposed research recording device (RRD) to record and convert recorded signals into various visual formats. Recordings will be observed by study staff to determine whether auditory acuity matches expected signals.

    Up to 30 days

  • Feasibility - convert audible doppler signal tracings to stored data files

    Ability to convert the recorded doppler signal tracings to stored data files for 80% of subjects. Analysis of the primary endpoint will be done in a binary (yes/no) fashion to describe the feasibility of the proposed RRD to record and convert recorded signals into various visual formats.

    Up to 30 days

Secondary Outcomes (1)

  • Feasibility - convert audible data to visual signal to a visual signal

    Up to 30 days

Other Outcomes (1)

  • AI algorithm

    Up to 2 years

Study Arms (1)

Observational

Patients undergo recording of the clinical Doppler monitor via an implanted research recording device (RRD) and have their medical records reviewed on study.

Other: Non-Interventional Study

Interventions

Non-interventional study

Also known as: Non-Interventional Observational Study, Noninterventional (Observational) Study
Observational

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled to undergo free flap surgery with an implantable doppler

You may qualify if:

  • Scheduled for free flap surgery and planned to have an implanted doppler monitor
  • Arterial Doppler waveforms available for analysis
  • Able and willing to sign consent and return for clinical follow up
  • Age ≥ 18 years

You may not qualify if:

  • Prior head and neck surgery within the region where surgeons plan to identify donor vessels ≤ 365 days prior to registration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Head and Neck Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Study Officials

  • Kathryn M. Van Abel, MD

    Mayo Clinic in Rochester

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Clinical Trials Referral Office

CONTACT

Colleen Dickman

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2026

First Posted

September 16, 2026

Study Start

September 17, 2026

Primary Completion (Estimated)

September 30, 2028

Study Completion (Estimated)

September 30, 2028

Last Updated

September 21, 2026

Record last verified: 2026-09

Locations